These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3874160)

  • 1. Impaired antigen presenting function of macrophages from aged mice.
    Vĕtvicka V; Tlaskalová-Hogenová H; Pospísil M
    Immunol Invest; 1985 Apr; 14(2):105-14. PubMed ID: 3874160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo.
    Hayglass KT; Naides SJ; Scott CF; Benacerraf B; Sy MS
    J Immunol; 1986 Feb; 136(3):823-9. PubMed ID: 2416835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to the p-azobenzenearsonate (ABA)-GAT conjugate: role of I region genes in the selective activation of ABA-specific or GAT-specific T helper cells.
    Seman M; Regnier D; Hermier B; Dubert JM
    J Immunol; 1982 Nov; 129(5):2082-8. PubMed ID: 6181159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of antigen presentation required for triggering of T cell response: analysis by use of azobenzenearsonate-tyrosine derivatives as antigens and L cells transfected with I-Ak genes as antigen presenting cells.
    Saito S; Tadakuma T; Inoko H; Saito K
    Mol Immunol; 1988 Jun; 25(6):569-75. PubMed ID: 3139994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells and macrophages as antigen presenting cells in ovalbumin-induced T lymphocyte proliferation in vitro.
    Kapsenberg ML; Stiekema FE; Teunissen MB
    Adv Exp Med Biol; 1985; 186():389-94. PubMed ID: 3876708
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of T cell unresponsiveness by augmentation of antigen presenting cell function.
    Doherty TM; Love SG; Harding DR; Watson JD
    Int Immunol; 1994 May; 6(5):761-8. PubMed ID: 7521669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar macrophages: antigen presentation activity in vivo.
    Holt PG; Leivers S
    Aust J Exp Biol Med Sci; 1985 Feb; 63 ( Pt 1)():33-9. PubMed ID: 3874620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of macrophage Ia and membrane IL 1 expression to antigen presentation.
    Kurt-Jones EA; Virgin HW; Unanue ER
    J Immunol; 1985 Dec; 135(6):3652-4. PubMed ID: 3934262
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine HIV-1 p24 specific T lymphocyte activation by different antigen presenting cells: B lymphocytes from immunized mice present core protein to T cells.
    Fyfe L; Maingay JP; Howie SE
    Immunol Lett; 1993 Jan; 35(1):45-50. PubMed ID: 8096202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition among class II major histocompatibility molecules for presentation of tyrosine-azobenzenearsonate occurs in vivo and in vitro.
    Baskar S; Leskowitz S
    Eur J Immunol; 1990 Mar; 20(3):587-93. PubMed ID: 2156709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anatomy of an antigen molecule: functional subregions of L-tyrosine-p-azobenzenearsonate.
    Godfrey WL; Lewis GK; Goodman JW
    Mol Immunol; 1984 Oct; 21(10):969-78. PubMed ID: 6209567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells as accessory cells in antigen-specific murine T lymphocyte proliferation in vitro.
    Teunissen MB; Kapsenberg ML; Stiekema FE; Keizer HG
    J Immunol Methods; 1985 Feb; 77(1):131-8. PubMed ID: 3871821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of Ia-positive antigen-presenting cells in autoimmune mice.
    Yamashita U
    Cell Immunol; 1986 Feb; 97(2):257-66. PubMed ID: 3488828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antigen-specific activation of an L3T4+ T cell line by cyclosporine with maintenance of macrophage-mediated antigen presentation.
    Lu CY; Lemay PA; Lombardi MJ
    Transplantation; 1988 Jan; 45(1):187-94. PubMed ID: 3257307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antigen presenting cell function following in vivo priming.
    De Becker G; Mockel P; Urbain J; Leo O; Moser M
    Adv Exp Med Biol; 1997; 417():189-93. PubMed ID: 9286360
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymosins alpha 1 and beta 4 potentiate the antigen-presenting capacity of macrophages.
    Tzehoval E; Sztein MB; Goldstein AL
    Immunopharmacology; 1989; 18(2):107-13. PubMed ID: 2807872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of the delayed hypersensitivity T effector and T suppressor cell response by antigen-presenting macrophages.
    Knop J; Malorny U; Michels E; Sorg C
    Immunobiology; 1984 Dec; 168(3-5):246-59. PubMed ID: 6241600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation.
    Kulkarni AB; Müllbacher A; Blanden RV
    Immunol Cell Biol; 1991 Apr; 69 ( Pt 2)():71-80. PubMed ID: 1680803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by proliferating thymic macrophages to A (T,G)-A-L specific T cell line in an H-2 restricted manner.
    Axelrod O; Mozes E; Gallily R
    Immunol Lett; 1985; 10(1):25-30. PubMed ID: 3874152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident salivary gland macrophages function as accessory cells in antigen-dependent T-cell proliferation.
    Pappo J; Ebersole JL; Taubman MA
    Immunology; 1988 Jan; 63(1):99-104. PubMed ID: 2828229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.